使用新型稳定化茎纳米颗粒探针测量人血清中流感血凝素茎特异性抗体依赖细胞介导的细胞毒性
研究开发了一种使用稳定化茎纳米颗粒探针检测人血清中针对流感血凝素茎部抗体的抗体依赖细胞介导的细胞毒性(ADCC)的新方案。在90份人血清中,63%(57/90)存在抗H1茎表位抗体;多价纳米颗粒探针比单价三聚体探针诱导的ADCC活性高2-6倍,且该活性主要由靶向广谱中和抗体表位的抗体介导。
要点
- 63%(57/90)人血清中存在抗H1茎表位抗体。
- 多价纳米颗粒探针诱导的ADCC活性较单价三聚体探针高2-6倍。
- ADCC活性主要由靶向HA茎部广谱中和抗体表位的抗体介导。
核心结论
- 建立了一种使用稳定化茎纳米颗粒探针测量茎特异性ADCC活性的方法,结果显示抗HA茎抗体具有交叉反应性ADCC活性且 prevalence 较高,该法可用于评估下一代流感疫苗。
研究设计与样本
- 使用三聚体稳定化茎或单价稳定化茎纳米颗粒(n=8个三聚体)形式,对不同流感第1组稳定化茎探针(H1、H2和H5)进行人血清结合和ADCC活性筛选。
主要发现
- 初始筛选显示63%(57/90)血清抗HA(H1)茎表位抗体阳性,通过HA稳定化茎与其对应表位突变体(Ile45Arg/Thr49Arg)探针的差异结合确定。
- 在等摩尔量下,多价纳米颗粒展示的HA稳定化茎诱导的ADCC活性显著高于单价(三聚体)稳定化茎探针(增加2-6倍)。
- 针对不同第1组流感亚型H1、H2和H5也报告了类似的ADCC活性。
- ADCC主要由靶向HA茎部广谱中和抗体表位的抗体介导。
关键数值与推荐
- 63%(57/90)血清抗HA(H1)茎表位抗体阳性。
- 多价纳米颗粒探针较单价三聚体探针ADCC活性增加2-6倍。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Generating vaccine that confers a complete protection is a major goal in designing a universal influenza vaccine. Currently, there is a considerable interest in the broadly neutralizing antibodies (bnAb) targeting the conserved HA stem region. These antibodies have been shown to activate cellular immune responses, such as ADCC, in addition to their neutralization activity. We had previously demonstrated that immunization with H1-based stabilized stem (SS) nanoparticles (np) protects against heterosubtypic lethal H5N1 challenge, despite the absence of detectable neutralizing activity. Utilizing these novel SS probes to develop an ADCC assay would help in understanding the mechanism of action of stem-specific antibodies, as well as evaluating future influenza vaccines. OBJECTIVES: To develop a new protocol to assess the ADCC activity mediated by stem-directed antibodies in human sera using novel SS np probes. STUDY DESIGN: Human sera samples were screened for binding and ADCC activities to different influenza group 1 SS probes (H1, H2, and H5) using trimeric SS or multivalent SS-np (n = 8 trimers) formats. RESULTS: Initial screening revealed 63% (57/90) seroprevalence of anti-HA (H1) stem-epitope antibodies, as determined by the differential binding to HA SS and its corresponding epitope-mutant (Ile45Arg/Thr49Arg) probe. Using equimolar amounts, the multivalent presentation of HA SS on np induced significantly higher ADCC activity compared to the monovalent (trimer) SS probes (2-6 fold increase). Further, ADCC activity was similarly reported against different group 1 influenza subtypes: H1, H2, and H5. Importantly, ADCC was mediated mainly by antibodies targeting the bnAb-epitope on the HA stem. CONCLUSION: We report on an assay to measure stem-specific ADCC activity using SS np probes. Our results indicate high prevalence of HA-stem antibodies with cross-reactive ADCC activity. Such assay could be utilized in the assessment of next generation influenza vaccines.
引用
- Smatti MK, Nasrallah GK, Al Thani AA, et al. Measuring influenza hemagglutinin (HA) stem-specific antibody-dependent cellular cytotoxicity (ADCC) in human sera using novel stabilized stem nanoparticle probes. Vaccine. 2019. PMID: 31735504. doi:10.1016/j.vaccine.2019.10.093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。